MARÍA ISABEL FABREGAT ROMERO-rekin lankidetzan egindako argitalpenak (7)

2022

  1. Lack of EGFR catalytic activity in hepatocytes improves liver regeneration following DDC-induced cholestatic injury by promoting a pro-restorative inflammatory response

    Journal of Pathology, Vol. 258, Núm. 3, pp. 312-324

2016

  1. Dissecting the role of epidermal growth factor receptor catalytic activity during liver regeneration and hepatocarcinogenesis

    Hepatology, Vol. 63, Núm. 2, pp. 604-619

2012

  1. Protein-tyrosine phosphatase 1B (PTP1B) deficiency confers resistance to transforming growth factor-β (TGF-β)-induced suppressor effects in hepatocytes

    Journal of Biological Chemistry, Vol. 287, Núm. 19, pp. 15263-15274

2004

  1. IRS-2 mediates the antiapoptotic effect of insulin in neonatal hepatocytes

    Hepatology, Vol. 40, Núm. 6, pp. 1285-1294

  2. Transforming growth factor-beta activates both pro-apoptotic and survival signals in fetal rat hepatocytes

    Experimental Cell Research, Vol. 292, Núm. 1, pp. 209-218

2003

  1. Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes

    Diabetes, Vol. 52, Núm. 9, pp. 2239-2248

2000

  1. Epidermal growth factor impairs the cytochrome C/caspase-3 apoptotic pathway induced by transforming growth factor β in rat fetal hepatocytes via a phosphoinositide 3-kinase-dependent pathway

    Hepatology, Vol. 32, Núm. 3, pp. 528-535